Your browser doesn't support javascript.
loading
MRSA surveillance programmes worldwide: moving towards a harmonised international approach.
Baede, Valérie O; David, Michael Z; Andrasevic, Arjana Tambic; Blanc, Dominique S; Borg, Michael; Brennan, Grainne; Catry, Boudewijn; Chabaud, Aurélie; Empel, Joanna; Enger, Hege; Hallin, Marie; Ivanova, Marina; Kronenberg, Andreas; Kuntaman, Kuntaman; Larsen, Anders Rhod; Latour, Katrien; Lindsay, Jodi A; Pichon, Bruno; Santosaningsih, Dewi; Schouls, Leo M; Vandenesch, François; Werner, Guido; Zabicka, Dorota; Zemlicková, Helena; Seifert, Harald; Vos, Margreet C.
Afiliação
  • Baede VO; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • David MZ; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Andrasevic AT; Department of Clinical Microbiology, University Hospital for Infectious Diseases, University of Zagreb School of Dental Medicine, Zagreb, Croatia.
  • Blanc DS; Hospital Preventive Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Swiss National Reference Center for Emerging Antibiotic Resistance, Lausanne site, Lausanne, Switzerland.
  • Borg M; Department of Infection Control, Mater Dei Hospital, Msida, Malta.
  • Brennan G; National MRSA Reference Laboratory, St James's Hospital, Dublin 8, Ireland.
  • Catry B; Healthcare-associated infections & antimicrobial resistance, Sciensano, Brussels, Belgium; Faculty of Medicine, Université libre de Bruxelles, Brussels, Belgium.
  • Chabaud A; Mission nationale SPARES (Surveillance et Prévention de l'AntibioRésistance en Etablissement de santé), Limoges University Hospital, Limoges, France.
  • Empel J; Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
  • Enger H; The Norwegian MRSA Reference Laboratory, St Olavs Hospital, Trondheim, Norway.
  • Hallin M; Department of Microbiology, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium.
  • Ivanova M; East-Tallinn Central Hospital Laboratory, Tallinn, Estonia.
  • Kronenberg A; Swiss Centre for Antibiotic Resistance, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
  • Kuntaman K; Department of Medical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Dr Soetomo General Academic Hospital, Surabaya, Indonesia.
  • Larsen AR; National Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Fungi and Parasites, Statens Serum Institut, Copenhagen, Denmark.
  • Latour K; Healthcare-associated infections & antimicrobial resistance, Sciensano, Brussels, Belgium.
  • Lindsay JA; Institute for Infection and Immunity, St George's, University of London, London, UK.
  • Pichon B; National Infection Service, Public Health England, London, UK.
  • Santosaningsih D; Department of Clinical Microbiology, Faculty of Medicine, Brawijaya University/Dr Saiful Anwar Hospital, Malang, Indonesia.
  • Schouls LM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Vandenesch F; Centre International de Recherche en Infectiologie (CIRI), Université de Lyon, INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France; Centre National de Référence des Staphylocoques, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
  • Werner G; Robert Koch Institute, Department of Infectious Diseases, National Reference Centre for Staphylococci and Enterococci, Wernigerode Branch, Germany.
  • Zabicka D; Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
  • Zemlicková H; National Reference Laboratory for Antibiotics, Centre for Epidemiology and Microbiology, National Institute of Public Health, 10000 Prague, Czech Republic; Department of Microbiology, 3rd Faculty of Medicine Charles University, University Hospital Kralovske Vinohrady and National Institute of Public
  • Seifert H; Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Köln, Germany.
  • Vos MC; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: m.vos@erasmusmc.nl.
Int J Antimicrob Agents ; 59(3): 106538, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35091055
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Infecções dos Tecidos Moles / Staphylococcus aureus Resistente à Meticilina Tipo de estudo: Guideline / Qualitative_research / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Infecções dos Tecidos Moles / Staphylococcus aureus Resistente à Meticilina Tipo de estudo: Guideline / Qualitative_research / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article